CD133 expression correlates with clinicopathologic features and poor prognosis of colorectal cancer patients: An updated meta-analysis of 37 studies

BACKGROUND: CD133 has been identified as a putative cancer stem cell marker in colorectal cancer (CRC). However, the clinicopathological and prognostic significance of CD133 in CRC patients remains controversial. Thus, we conducted a meta-analysis to quantitatively evaluate the above issues. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Rongyong, Mo, Dan, Wu, Junrong, Ai, Huaying, Lu, Yiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999490/
https://www.ncbi.nlm.nih.gov/pubmed/29879012
http://dx.doi.org/10.1097/MD.0000000000010446

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999490/
https://www.ncbi.nlm.nih.gov/pubmed/29879012
http://dx.doi.org/10.1097/MD.0000000000010446

Ejemplares similares